The characteristics of remnant lipoproteins in the fasting and postprandial plasma

Clinica Chimica Acta

Volumn 413, Issue 13-14, 2012, Pages 1077-1086

  Nakajima, Katsuyuki ^a,b,c,d,f   Nakano, Takamitsu ^a,b   Tokita, Yoshiharu ^a   Nagamine, Takeaki ^a   Yatsuzuka, Shin ichi ^c   Shimomura, Younosuke ^c   Tanaka, Akira ^d   Sumino, Hiroyuki ^e   Nara, Makoto ^e   Machida, Tetsuo ^e   Murakami, Masami ^e  

^a GUNMA UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c Hidaka Hospital   (Japan)

^d KAGAWA NUTRITION UNIVERSITY   (Japan)

^e GUNMA UNIVERSITY   (Japan)

^f NONE   (Japan)

Author keywords

ApoB 100; ApoB 48; Chylomicron (CM) remnants; RLP cholesterol (RLP C); RLP triglyceride (RLP TG); Very low density lipoprotein (VLDL) remnants

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; REMNANT LIKE LIPOPROTEIN PARTICLE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAT INTAKE; FOOD DEPRIVATION; HUMAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; POSTPRANDIAL STATE; PRIORITY JOURNAL; REFERENCE VALUE;

EID: 84860377045     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.02.026     Document Type: Article

References (48)

1. Nakajima K., Saito T., Tamura A., et al. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gel. Clin Chim Acta 1993, 223:53-71.
2. McNamara J.R., Shah P.K., Nakajima K., et al. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study. Atherosclerosis 2001, 154:229-237.
3. Nakajima K., Nakano T., Tanaka A. Article title: The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta 2006, 367:36-47.
4. Nakajima K., Nakano T., Tokita Y., et al. Postprandial lipoprotein metabolism: VLDL vs chylomicrons. Clin Chim Acta 2011, 412:1306-1318.
5. Nakano T., Tokita Y., Nagamine T., et al. Measurement of serum remnant-like lipoprotein particle-triglyceride (RLP-TG) and RLP-TG/total TG ratio using highly sensitive triglyceride assay reagent. Clin Chim Acta 2011, 412:71-78.
6. Nakajima K., Nakano T., Moon H.D., et al. The correlation between TG vs remnant lipoproteins in the fasting and postprandial plasma of 23 volunteers. Clin Chim Acta 2009, 404:124-127.
7. Nakano T., Tanaka A., Okazaki M., Tokita Y., Nagamine T., Nakajima K. Particle size of apoB-48 carrying lipoproteins in remnant lipoproteins isolated from postprandial plasma. Ann Clin Biochem 2011, 48:57-64.
8. Akuzawa K., Nakano T., Sekiguchi I., et al. Remnant-like particles-cholesterol (RLP-C) assay and its clinical application to lipid tests in a postprandial as well as fasting state [Article in Japanese]. Rinsho Byori 1995, 43:1159-1167.
9. Kasama T., Yoshino G., Iwatani I., et al. Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics. Atherosclerosis 1987, 63:263-266.
10. Masuda D., Sakai N., Sugimoto T., et al. Fasting serum apolipoprotein B-48 Can be a marker of postprandial hyperlipidemia. J Atheroscler Thromb 2011, 22(18):1062-1070.
11. Kinoshita M., Kojima M., Matsushima T., Teramoto T. Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta 2005, 351:115-120.
12. Usui S., Hara Y., Hosaki S., Okazaki M. A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. J Lipid Res 2002, 43:805-814.
13. Tanaka A., Tomie N., Nakano T., et al. Measurement of postprandial remnant-like particles (RLP) following a fat-loading test. Clin Chim Acta 1998, 275:43-52.
14. Guidelines for prevention of atherosclerotic cardiovascular diseases 2007, Japan Atherosclerosis Society (JAS).
15. Nakajima K., Okazaki M., Tanaka A., et al. Separation and determination of remnant-like particles in serum from diabetes patients using monoclonal antibodies to apo B-100 and apo A-I. J Clin Ligand Assay 1996, 19:177-183.
16. Okazaki M., Usui S., Tada N., Nakano T., Nakajima K. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in cholesterol profiles by HPLC. Clin Chim Acta 2000, 296:135-149.
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). JAMA 2001, 85(19):2486-2497.
18. Zilversmit D.B. Atherogenesis: a postprandial phenomenon. Circulation 1979, 60:473-485.
19. Syvänne M., Hilden H., Taskinen M.R. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease. J Lipid Res 1994, 35:15-26.
20. Altena T.S., Michaelson J.L., Ball S.D., Guilford B.L. Thomas TR Lipoprotein subfraction changes after continuous or intermittent exercise training. Med Sci Sports Exerc 2006 Feb, 38(2):367-372.
21. Christensen B., Gluek C., Kwiterovich P., et al. Plasma cholesterol and triglyceride distributions in 13,665 children and adolescents: the prevalent study of the lipid research clinics program. Pediatr Res 1980, 14:194-201.
22. Jackson K.G., Knapper-Francis J.M., Morgan L.M., Webb D.H., Zampelas A., Williams C.M. Exaggerated postprandial lipaemia and lower post-heparin lipoprotein lipase activity in middle-aged men. Clin Sci (Lond) 2003 Oct, 105(4):457-466.
23. Nakajima K., Kobayashi J., Mabuchi H., et al. Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma. Ann Clin Biochem 2010, 47:423-431.
24. Shimada M., Ishibashi S., Inaba T., et al. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc Natl Acad Sci USA 1996 Jul 9, 93(14):7242-7246.
25. Austin M.A., King M.C., Vranizan K.M., Krauss R.M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990 Aug, 82(2):495-506.
26. BjoÈrkegren J., Packard C.J., Hamsten A., et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996, 37:76-86.
27. Karpe F., Hultin M. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway. J Lipid Res 1995, 36:1557-1566.
28. Karpe F., HelleÂnius M.-L., Hamsten A. Differences in postprandial concentrations of very low density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary artery disease. Metabolism 1999, 48:301-307.
29. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 1999, 246:341-355.
30. Marcoux C., Hopkins P.N., Wang T., et al. Remnant-like particle cholesterol and triglyceride concentrations of hypertriglyceridemic patients in the fed and fasted state. J Lipid Res 2000, 41:1428-1436.
31. Deighan C.J., Caslake M.J., McConnell M., Boulton-Jones J.M., Packard C.J. The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria. Atherosclerosis 2001, 157:211-220.
32. Okamoto H., Miyai A., Sasase T., et al. Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma. Clin Chim Acta 2007, 375:92-98.
33. Inazu A., Nakajima K., Nakano T., et al. Decreased post-prandial triglyceride response and diminished remnant lipoprotein formation in cholesteryl ester transfer protein (CETP) deficiency. Atherosclersois 2008, 196:953-957.
34. Ai M., Tanaka A., Shimokado K., et al. A deficiency of cholesteryl ester transfer protein whose serum remnant-like particle-triglyceride significantly increased, but serum remnant-like particle-cholesterol did not after an oral fat load. Ann Clin Biochem 2009, 46:457-463.
35. Fielding C.J., Havel R.J., Todd K.M., et al. Effects of dietary cholesterol and fat saturation on plasma lipoproteins in an ethnically diverse population of healthy young men. J Clin Invest 1995, 95:611-618.
36. Tall A.R., Sammett D., Vita G.M., Deckelbaum R., Olivecrona T. Lipoprotein lipase enhances the cholesteryl eater transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins. J Biol Chem 1984, 259:9587-9594.
37. Deighan C.J., Caslake M.J., McConnell M., Boulton-Jones J.M., Packard C.J. The atherogenic lipoprotein phenotype: small dense LDL and lipoprotein remnants in nephrotic range proteinuria. Atherosclerosis 2001, 157:211-220.
38. Miller M., Cannon C.P., Murphy S.A., Qin J., Ray K.K., Braunwald E. PROVE IT-TIMI 22 Investigators. Impact of triglyceride concentrations beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2008 Feb 19, 51(7):724-730.
39. Miller M., Stone N., Ballantyne B., et al. Triglycerides and cardiovascular disease. Scientific statement from the American Heart Association. Circulation 2011, 123:2292-2333.
40. Yin W., Tsutsumi K. Lipoprotein lipase activator NO-1886. Cardiovasc Drug Rev 2003, 21:133-142. Review.
41. Fojo S.S., Brewer H.B. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med 1992, 23:669-677.
42. Demacker P.N., Bredie S.J., Vogelaar J.M., et al. Beta-VLDL accumulation in familial dysbetalipoproteinemia is associated with increased exchange or diffusion of chylomicron lipids to apo B-100 containing triglyceride-rich lipoproteins. Atherosclerosis 1998, 138:301-312.
43. Meng M.S., Gregg R.E., Schaefer E.J., Hoeg J.M., Brewer H.B. Presence of two forms of apolipoprotein B in patients with dyslipoproteinemia. J Lipid Res 1983, 24:803-809.
44. Kane J.P., Chen G.C., Hamilton R.L., Hardman D.A., Malloy M.J., Havel R.J. Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia. Arteriosclerosis 1983, 3:47-56.
45. Haffner S.M., Kushwaha R.S., Hazzard W.R. Metabolism of chylomicrons in subject with dysbetalipoproteinaemia (type III hyperlipoproteinaemia). Eur J Clin Invest 1989, 19:486-490.
46. Cohn J.S., Johnson E.J., Millar J.S., et al. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 1993, 34:2033-2040.
47. Gotoda T., Shirai K., Ohta T., et al. Diagnosis and management of Type I and Type V hyperlipoproteinemia. J Atheroscler Thromb Dec 1 2011, [Epub ahead of print].
48. Phillips N.R., Waters D., Havel R. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993, 88:2762-2770.